Kyowa Kirin North America Appoints Paula Soteropoulos to Board of Directors
BEDMINSTER, N.J., Sept. 27, 2021 /PRNewswire/ --Kyowa Kirin, Inc., an affiliate of Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE: 4151) a global specialty pharmaceutical company, welcomed Paula Soteropoulos, a biopharma industry veteran, as the newest non-executive Director on its North America Board of Directors, effective September 1, 2021.